Wichtig to publish Tumori Journal

Wichtig to publish Tumori Journal

Editorial by

Beginning in 2015, Wichtig Publishing Srl will publish Tumori Journal the official publication of the National Tumori Institute in Milan, Italy, founded in 1928 and a European center of excellence for oncological research.

Wichtig won the tender launched by the Institute in 2014 to select a new STM publishing partnership for the journal. This agreement will enable the journal to expand and strengthen its mission to stimulate advancements in oncology, focusing on experimental and clinical cancer research. The journal will continue to be affiliated with the main Italian oncological associations. Articles will be available on Wichtig’s online platform, as well as several databases that host Wichtig content including EBSCO, Ovid and others. Founded in 1911 by Professor Gaetano Fichera as Tumori, the Journal is one of the oldest oncology journals and it is published six times a year.

“We are very committed to establishing Tumori Journal as one of the leading publications in the field” said Dr. Ugo Pastorino, Scientific Director of the National Tumori institute and newly appointed Editor-in-Chief. “The journal, which has already attracted a growing number of important contributions worldwide under the skillful direction of Dr Zunino, will undergo a complete upgrade of its editorial and publishing model, including rapid peer review and advance online publication, and will be available in the library of the most respected cancer institutions worldwide.”

“Tumori Journal is a very important addition to our growing portfolio of specialist journals” added Dr. Giulio Zuanetti, CEO of Wichtig “and will establish our company as an important publisher in oncology, we already publish The International Journal of Biological Markers and The Journal of Vascular Access. We look forward to a successful partnership with the National Tumori Institute and affiliated scientific societies.”

Please make sure that you have installed the Profile Builder plugin.